BPC-157 — 10mg
- 3 vials — 3% discount
- 5 vials — 5% discount
- 10 vials — 10% discount
- 11+ vials — contact us
High Purity
Lyophilised for maximum stability and shelf life.
Third-Party Tested
Analytical testing — HPLC, sterility, endotoxins.
Quality Control
Manufactured under strict process standards.
Batch-Specific COA
Transparency you can trust.
Overview
BPC-157 (Body Protective Compound 157) for research use only, is a synthetic pentadecapeptide derived from a protective protein originally identified in human gastric juice. It is one of the most extensively studied compounds in regenerative peptide research, with a substantial body of in vitro and in vivo literature.
This vial contains 10mg of BPC-157, supplied lyophilised (freeze-dried), research grade, in a sealed vial. Each batch is supplied with a Certificate of Analysis confirming purity and identity testing carried out at the point of manufacture, published on this page before sale.
BPC-157 is investigated in research contexts including localised tissue repair models, angiogenesis and vascular signalling, gastrointestinal protection, and neuroprotection studies. Velyx makes no health claims about this compound.
What's included
- 1 × BPC-157 10mg vial — lyophilised, research grade
- Tracked UK delivery
Research use only. Not for human or veterinary consumption. By purchasing you confirm you are 18 or over and understand the research-use-only nature of this product.
Research
Fields of study
BPC-157 appears in peer-reviewed research literature on:
- Gastrointestinal protection and ulcer healing models
- Tendon and ligament repair studies
- Angiogenesis and vascular signalling
- Neuroprotection and central nervous system research
- Wound healing and tissue regeneration
Related research — selected papers
- Sikiric P et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011. PMID: 21443487
- Chang CH et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011. PMID: 21030672
- Seiwerth S et al. BPC 157 and standard angiogenic growth factors. Curr Pharm Des. 2018. PMID: 29998800
Velyx publishes peer-reviewed research citations for context only. No therapeutic claim is made or implied.
Certificates of Analysis
This vial of BPC-157 10mg ships with its batch-specific Certificate of Analysis using validated chromatographic and spectrometric techniques. The COA displayed below corresponds to the exact batch you receive.
- BPC-157 10mg — Batch 26107 — Download COA PDF
Each batch is supplied with documentation from our manufacturing partner covering HPLC purity, identity verification, endotoxin (LAL assay), heavy metals (Class 1 and 2), and bioburden (TAMC and TYMC) testing. Independent third-party verification is the next stage of our quality programme.
COA will be published here before this batch ships.
Preparation & Storage
Reconstitution
This vial arrives lyophilised (freeze-dried powder) and requires reconstitution with bacteriostatic water before use in research.
Storage
- Before reconstitution (lyophilised): refrigerate at 2–8°C. Avoid light. Do not freeze.
- After reconstitution: refrigerate at 2–8°C. Use within 14–30 days.
- In transit: shipped with insulated packaging.
Bacteriostatic water is not included. Available as a Velyx add-on.
All products sold by Velyx Research Ltd are for research purposes only and are not intended for human consumption. By purchasing from this site you confirm that you are 18 or over and understand the research-use only nature of all products.
Reviews
Verified customer reviews will appear here as orders ship and reviews are submitted. All reviews are post-purchase and unincentivised.